EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tubular Epithelia-Specific Deletion of MCP-1 Does Not Afford Protection Against Adriamycin-Induced Kidney Injury

Corry D Bondi, Hannah L Hartman, Josie L Gilbert, Joy A Stewart, Dennis R Clayton, Roderick J Tan iD

International Journal of Molecular Sciences · 06.03.2026 · 27 (5) · 2432

DOI: 10.3390/ijms27052432 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.03.2026. Verfasst von Corry D Bondi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, PA 152671, USA. Hauptthemen laut MEDLINE: Chemokine CCL2, Doxorubicin, Kidney Tubules. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, BLRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing global burden of chronic kidney disease (CKD) magnifies an urgent need to find treatable targets. Monocyte chemoattractant protein-1 (MCP-1/CCL2) is a chemokine secreted by kidney tubular epithelia in response to a variety of stimuli. To better understand the effects of tubular MCP-1 in response to kidney injury, we generated tubular epithelia-specific MCP-1 knockout mice (KO; Pax8-Mcp-1fl/fl). We then exposed these mice and their control littermates to Adriamycin (Adr; 18 mg/kg, IV bolus). Thirty-two days after Adr injection, Mcp-1 transcript and protein levels were suppressed in the KO mice compared to their wild-type (WT) littermates. The KO mice exhibited no effect on survival, change in body weight, albuminuria, kidney function, glomerular or tubular injury, or tubulointerstitial fibrosis compared to WT. Overall, the results suggest that tubule-secreted MCP-1 is not necessary for progression of Adr-induced injury. These findings contribute to our understanding of the role of MCP-1 in kidney injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokine CCL2DoxorubicinKidney TubulesAnimalsMice, KnockoutMiceGene DeletionMale

Stichwörter der Autor:innen

CCL2chemokinechronic kidney diseaseglomerular injurytubular injury

Substanzen

Chemokine CCL2DoxorubicinCcl2 protein, mouse

Autor:innen und Institutionen

  • Department of Medicine, Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, PA 152671, USA.
  • Kidney Medicine Section, Medical Service, VA Pittsburgh Healthcare System, Pittsburgh, PA 15212, USA.

ORCID-Profile: Roderick J Tan

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • BLRD VA
  • American Society of Nephrology Carl W. Gottschalk Research Scholar Grant
  • Department of Veterans Affairs Merit Award
  • National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases
  • Pittsburgh Center for Kidney Research
  • NIDDK

Zitieren

APA

Bondi, C. D., Hartman, H. L., Gilbert, J. L., Stewart, J. A., Clayton, D. R., & Tan, R. J. (2026). Tubular Epithelia-Specific Deletion of MCP-1 Does Not Afford Protection Against Adriamycin-Induced Kidney Injury. International Journal of Molecular Sciences, 27(5), 2432. https://doi.org/10.3390/ijms27052432

Vancouver

Bondi CD, Hartman HL, Gilbert JL, Stewart JA, Clayton DR, Tan RJ. Tubular Epithelia-Specific Deletion of MCP-1 Does Not Afford Protection Against Adriamycin-Induced Kidney Injury. International Journal of Molecular Sciences. 2026;27(5):2432. doi:10.3390/ijms27052432

BibTeX
@article{Bondi2026,
  author = {Bondi, Corry D and Hartman, Hannah L and Gilbert, Josie L and Stewart, Joy A and Clayton, Dennis R and Tan, Roderick J},
  title = {Tubular Epithelia-Specific Deletion of MCP-1 Does Not Afford Protection Against Adriamycin-Induced Kidney Injury},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {5},
  pages = {2432},
  doi = {10.3390/ijms27052432}
}
Kostenlos starten →